Current Treatment Options in Oncology

Papers
(The TQCC of Current Treatment Options in Oncology is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Role of Metastasis-Directed Therapy in Genitourinary Cancers178
Antibody-Drug Conjugates for Melanoma and Other Skin Malignancies122
Advances in the Pathogenesis, Diagnosis, Treatment, and Prognosis of Marginal Zone Lymphoma91
Correction to: Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead78
“Off-the-Shelf” Allogeneic CAR Cell Therapy—Neglected HvG Effect61
Current Therapeutic Landscape in Lower Risk Myelodysplastic Syndromes61
Whole Abdominal Radiotherapy in Bone and Soft Tissue Sarcomas: Indications, Techniques, Clinical Outcomes, and Future Directions56
An Update on Temporal Bone Paragangliomas55
Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer54
Clinical Application of Artificial Intelligence for Non-melanoma Skin Cancer53
Current Approaches of Immune Checkpoint Therapy in Chronic Lymphocytic Leukemia46
Combining Radiotherapy with Immunotherapy in Cervical Cancer: Where Do We Stand and Where Are We Going?44
Management of Fatigue in Patients with Advanced Cancer43
Options and Considerations in the Management of Peritoneal Disease in Patients with Small Bowel Neuroendocrine Tumors43
Recent Advances in Liver Transplantation for Hepatocellular Carcinoma40
Enhanced Photodynamic Therapy by Improved Light Energy Capture Efficiency of Porphyrin Photosensitizers36
Approach to Localized Squamous Cell Cancer of the Esophagus36
Small Cell Lung Cancer—An Update on Chemotherapy Resistance35
The Role of Nursing in the Delivery of Cardio-Oncology35
The Review of Modified Intersphincteric Resection in the Treatment of Ultra-Low Rectal Cancer34
Advances in Targeted Therapy for Metastatic Prostate Cancer34
Current Practice in Carcinoid Heart Disease and Burgeoning Opportunities32
Targets Selection for Precision Therapy of Relapsed/Refractory Multiple Myeloma: the Latest Advancements31
Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer31
Regorafenib for the Treatment of Sarcoma30
Revolutionizing Breast Cancer Therapeutics: Intersecting Frontiers of Precision Medicine, Nanotechnology, and Drug Delivery Innovations30
Essential Thrombocythemia in Adolescents and Young Adults: Clinical Aspects, Treatment Options and Unmet Medical Needs29
Proposals for Clinical Trials in Chronic Myelomonocytic Leukemia28
Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma: from Bench to Bedside?26
Telemedicine and Virtual Reality Technologies in Pain Management for Cancer Patients: A Structured Narrative Review26
Gastric Cancer with Sarcopenia: an Area Worth Focusing On26
Steroid Premedication and Monoclonal Antibody Therapy: Should We Reconsider?26
Application of Engineered Dendritic Cell Vaccines in Cancer Immunotherapy: Challenges and Opportunities25
Recognition and Management of the Long-term Effects of Cranial Radiation25
Endocrinologic Toxicities of Cancer Therapy: Evolving Challenges and Multidisciplinary Approaches25
A Comprehensive Review on the Role of Lurbinectedin in Soft Tissue Sarcomas25
R0 Resection in Recurrent Gynecologic Malignancy: Pelvic Exenteration and Beyond24
Review of Bone Metastasis in Gynecologic Malignancies: Evaluation and Treatment24
Response Evaluation of Neoadjuvant Therapies in Sarcoma24
Dyadic Interventions for LGBTQ+ Individuals Facing Cancer: A Narrative Review23
Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors23
New Therapeutic Targets in RAS Wild-type Pancreatic Cancer23
Contemporary Review of Adenocarcinoma of the Cervix22
Transforming a Roadblock into a Roadmap: Evolving HFSR Management From Adverse Event to Efficacy Biomarker22
Treatment Options for Brain Metastases22
Evolution of Treatment Strategies for Gestational Trophoblastic Neoplasia: Chemotherapy, Immunotherapy, and Molecular Targeted Therapy22
Research Progress on Ferroptosis in Multiple Myeloma21
Navigating PARP Inhibitor Resistance in Ovarian Cancer: Bridging Mechanistic Insights To Clinical Translation21
Novel Estrogen Receptor-Targeted Agents for Breast Cancer21
Neoadjuvant and Adjuvant Therapy Approaches to Gastric Cancer21
One Size Fits Some: Approaching Rare Malignancies of the Urinary Tract21
Approach to Stereotactic Body Radiotherapy for the Treatment of Advanced Hepatocellular Carcinoma in Patients with Child-Pugh B-7 Cirrhosis21
Therapeutic Challenges in the Management of Serous Endometrial Intraepithelial Carcinoma (SEIC)21
Understanding, Recognizing, and Managing Cancer-Related Fatigue Associated with Breast Cancer20
Perioperative Immune Checkpoint Inhibitors for the Treatment of Locally Advanced Gastric and Gastroesophageal Junction Cancer: Current Status and Future Prospects20
Progress in the Treatment of Small Intestine Cancer20
Updates in Management of Malignant Pleural Mesothelioma20
New Developments in Systemic Management for High-Risk Early-Stage Hormone-Receptor-Positive, HER2-Negative Breast Cancer20
Perioperative Chemotherapy for Liver Metastasis of Colorectal Cancer: Lessons Learned and Future Perspectives19
Advancing Bladder Cancer Management: The Role of Neoadjuvant and Adjuvant Therapies and Biomarkers in Muscle Invasive Bladder Cancer19
Immunotherapy in the Treatment of Undifferentiated Pleomorphic Sarcoma and Myxofibrosarcoma19
Updates in Breast Cancer Screening and Diagnosis19
New Insights into the Understanding of Mechanisms of Radiation-Induced Heart Disease19
Neoadjuvant Photodynamic Therapy: An Updated Therapeutic Approach for Non-Melanoma Skin Cancers18
Re-thinking the Role of Thoracic Radiotherapy in the First-Line Treatment for Extensive-Stage Small Cell Lung Cancer18
What are the Optimal Systemic Treatment Options for Rhabdomyosarcoma?18
Treatment of Non-Small Cell Lung Cancer with Atypical EGFR Mutations18
Optimal First-Line Therapy for Metastatic Adenocarcinoma of the Esophagus17
Hypnosis for Symptom Management in Adult Cancer Patients: What is the Evidence?17
The Role of Induction Therapy for Sinonasal Cancers17
“When Less is More”: Paradigm Shifts in Radiation Treatment for Early-Stage Breast Cancer17
Taxane-Associated Acute Pain Syndrome: a Review of its Features and Management17
New Developments in Treating RAS-Mutated Metastatic Colorectal Cancer17
Myxoid Liposarcomas: Systemic Treatment Options17
The Role of SIRT1 in Leukemia17
A Review on Integrating Breast Cancer Clinical Data: A Unified Platform Perspective17
Enhancing Colorectal Cancer Treatment Through VEGF/VEGFR Inhibitors and Immunotherapy17
Correction to: Voluntary Assisted Dying/Euthanasia: Will This Have an Impact on Cancer Care in Future Years?16
Metastatic Castration-Resistant Prostate Cancer: Advances in Treatment and Symptom Management16
Extent of Resection and Outcomes of Patients with Primary Malignant Brain Tumors16
Therapeutic Management of Malignant Wounds: An Update16
Advances in PSMA-Targeted Radionuclide Therapeutics16
Correction to: Recent Advances in Succinate Dehydrogenase Deficient Gastrointestinal Stromal Tumor Systemic Therapies16
Management of Functional Pancreatic Neuroendocrine Neoplasms16
Targeting the Renin–angiotensin–aldosterone System (RAAS) for Cardiovascular Protection and Enhanced Oncological Outcomes: Review16
RAS and Other Molecular Targets in Pancreatic Cancer: The Next Wave Is Coming15
HER2-Positive Metastatic Colorectal Cancer15
Management and Treatment of Non-small Cell Lung Cancer with MET Alteration and Mechanisms of Resistance15
Diagnosis and Treatment of Myxoid Liposarcoma14
Emerging Therapeutic Approaches to Pancreatic Adenocarcinoma: Advances and Future Directions14
Immunotherapy for Metastatic Triple Negative Breast Cancer: Current Paradigm and Future Approaches14
Measurable Residual Disease in Chronic Lymphocytic Leukemia: Current Understanding and Evolving Role in Clinical Practice14
Advancements in Melanoma Therapies: From Surgery to Immunotherapy14
Radiotherapy for Advanced Esophageal Cancer: from Palliation to Curation14
Systemic Therapy for Salivary Gland Cancers: A Review of Targeted and Chemotherapeutic Approaches14
Correction to: Surgical Management and Considerations for Patients with Localized High-Risk Prostate Cancer14
ctDNA to Guide Treatment of Colorectal Cancer: Ready for Standard of Care?14
Dermatofibrosarcoma Protuberans (DFSP): Diagnostics and Molecular Pathology14
Neuroendocrine Tumors: Germline Genetics and Hereditary Syndromes13
Systemic and Targeted Therapies in Adenoid Cystic Carcinoma13
Systemic Management of Advanced Adrenocortical Carcinoma13
Community Palliative Care: What are the Best Models?13
Innovations in Cardio-oncology Resulting from the COVID-19 Pandemic13
The Improving Outcomes in Relapsed-Refractory Diffuse Large B Cell Lymphoma: The Role of CAR T-Cell Therapy13
Impact of PSMA PET on Prostate Cancer Management13
0.087009906768799